EyeCon 2021 to cover hot topics: nAMD, gene therapy for retinal disease, sustained drug delivery


EyeCon co-chairs Peter J. McDonnell, MD, and Oluwatosin U. Smith, MD, discuss the virtual conference and its relevance to ophthalmologists across the country.

The Ophthalmology Times® Inaugural EyeCon 2021 virtual interactive conference featuring renowned investigators is slated for December 10-11, 2021, and registration is now open. The sessions will run from 8:30 am to 3:55 pm on both days.

EyeCon co-chairs Peter J. McDonnell, MD, and Oluwatosin U. Smith, MD, sit down with Modern Retina's Sheryl Stevenson to discuss the conference and its relevance to ophthalmologists across the country.

The planned topics to look forward to, according to Drs. McDonnell and Smith, include advances in older topics of interest to ophthalmologist and updates on treatments on the horizon, many of these life-changing. These discussions include investigational and newly approved therapies for geographic atrophy, neovascular age-related macular degeneration, thyroid eye disease, and neuromyelitis optica spectrum disease; sustained drug delivery and minimally invasive glaucoma surgery; advances in cataract and refractive surgery; gene therapy for retinal disease and other ocular conditions; telemedicine during COVID-19; and the latest strategies for managing common concerns, including uveitis, presbyopia, and dry eye disease.

The conference, co-chaired by Peter J. McDonnell, MD, director of the Wilmer Eye Institute, and Texas-based glaucoma specialist Oluwatosin U. Smith, MD, associate professor, Department of Ophthalmology, University of Texas Southwestern, Dallas, will bring together the nation’s top ophthalmology experts to share new data and clinical insight into the most current processes and therapeutics.

Don’t miss this opportunity to access information on the latest insights and advancements in a variety of ophthalmic topics and get CME credits at the same time!

Participants will have the opportunity to optimize the use of imaging and other diagnostic tools for earlier identification of ocular diseases, improve team-based interactions with other eye-care specialists and health care providers when treating patients with systemic diseases contributing to vision loss, gain confidence in the use of new and emerging therapies and procedures in the ophthalmology setting, and interact with expert faculty to implement key learnings into practice.

Don’t miss out! Use this link for more information on the conference agenda, faculty, and registration.

Related Content: AAO Content | Ophthalmology | Conference Coverage

Related Videos
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
© 2024 MJH Life Sciences

All rights reserved.